These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3927468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
    Lieberman AN, Gopinathan G, Neophytides A, Hiesiger E, Nelson J, Walker R, Goodgold A.
    N Y State J Med; 1984 Jan; 84(1):13-6. PubMed ID: 6422358
    [No Abstract] [Full Text] [Related]

  • 4. Deprenyl and levodopa and Parkinson's disease progression.
    Fowler JS, Fazzini E, Volkow ND.
    Ann Neurol; 1996 Aug; 40(2):267-8. PubMed ID: 8773616
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pergolide and selegiline for Parkinson's disease.
    Med Lett Drugs Ther; 1989 Sep 08; 31(800):81-3. PubMed ID: 2505028
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C, Schumacher HC, Burgut FT.
    Expert Rev Neurother; 2005 Nov 08; 5(6):811-21. PubMed ID: 16274338
    [Abstract] [Full Text] [Related]

  • 11. R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
    Tetrud JW, Langston JW.
    J Neural Transm Suppl; 1987 Nov 08; 25():69-79. PubMed ID: 3123606
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deprenyl in Parkinson's disease.
    Korczyn AD, Nisipeanu P.
    Ann Neurol; 1996 Aug 08; 40(2):268-9. PubMed ID: 8773617
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MAO-B inhibitor know-how: back to the pharm.
    Lewitt PA.
    Neurology; 2009 Apr 14; 72(15):1352-7. PubMed ID: 19365057
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.